Robert Green

Robert Green current photo

Robert C. Green, MD, MPH is a medical geneticist and physician-scientist who directs the G2P Research Program ( in translational genomics and health outcomes in the Division of Genetics at Brigham and Women’s Hospital and Harvard Medical School. Dr. Green is internationally recognized for designing and conducting empirical studies in genomic medicine. He led the first experimental trials disclosing common complex disease risk (the REVEAL Study), one of the first prospective studies of direct-to-consumer genetic testing services (the PGen Study) and was lead author on influential recommendations for incidental findings in clinical sequencing from the American College of Medical Genetics and Genomics. He currently leads and co-leads the MedSeq Project and the BabySeq Project, respectively, two NIH-funded randomized trials designed to explore the medical, behavioral and economic implications of integrating genome sequencing into the medical care of adults and newborns.

More Speakers